Wellington Management Group LLP
Company profile
Employees
Incorporated
Location
Fiscal year end
Former names
Wellington Management Co, Wellington Management Co LLP
SEC CIK
Corporate docs
IRS number
42683227
Investment data
| Top 50 of 1768 long holdings End of quarter 30 Jun 20 |
Value |
#Shares |
|---|---|---|
| $14.27B | 70.13M | |
| $11.84B | 32.45M | |
| $10.02B | 33.96M | |
| $8.2B | 250.85M | |
| $6.98B | 2.53M | |
| $6.6B | 4.66M | |
| $6.26B | 33.92M | |
| $5.49B | 231M | |
| $5.3B | 44.34M | |
| $5.1B | 20.36M | |
| $4.86B | 108.78M | |
| $4.85B | 21.37M | |
| $4.79B | 52.21M | |
| $4.77B | 102.19M | |
| $4.71B | 120.87M | |
| $4.7B | 92.97M | |
| $4.68B | 26.46M | |
| $4.44B | 17.17M | |
| $4.43B | 20.55M | |
| $4.43B | 26.99M | |
| $4.31B | 45.83M | |
| $4.05B | 28.77M | |
| $3.95B | 23.39M | |
| $3.93B | 10.76M | |
| $3.9B | 65.19M | |
| $3.74B | 63.65M | |
| $3.66B | 66.4M | |
| $3.28B | 35.93M | |
| $3.27B | 42.34M | |
| $3.23B | 40.31M | |
| $3.02B | 5.55M | |
| $2.94B | 80.96M | |
| $2.92B | 23.03M | |
| $2.89B | 17.06M | |
|
Astrazeneca PLC
|
$2.88B | 54.54M |
| $2.86B | 30.03M | |
| $2.81B | 7.75M | |
| $2.79B | 14.46M | |
| $2.77B | 10.54M | |
| $2.77B | 34.12M | |
|
Raytheon Technologies Corp
|
$2.69B | 43.69M |
| $2.67B | 21.05M | |
| $2.53B | 11.8M | |
| $2.52B | 16.05M | |
| $2.49B | 18.86M | |
| $2.48B | 28.85M | |
| $2.32B | 22.06M | |
| $2.29B | 15.34M | |
| $2.28B | 3.66M | |
| $2.25B | 28.15M |
Holdings list only includes long positions.
Only includes long positions.
Calendar
20 Sep 20
31 Dec 20
News
Financial reports
No filings
Current reports
No filings
Registration and prospectus
No filings
Proxies
No filings
Other
No filings
Ownership
SC 13G
LEVI STRAUSS & CO / WELLINGTON MANAGEMENT ownership change
9 Sep 20
SC 13G/A
Community Bankers Trust / WELLINGTON MANAGEMENT ownership change
9 Sep 20
SC 13G/A
Odonate Therapeutics / WELLINGTON MANAGEMENT ownership change
9 Sep 20
SC 13G/A
Bandwidth / WELLINGTON MANAGEMENT ownership change
9 Sep 20
SC 13G/A
G1 Therapeutics / WELLINGTON MANAGEMENT ownership change
9 Sep 20
13F-HR
Quarterly holdings report by institutional manager
14 Aug 20
SC 13G
Nurix Therapeutics / WELLINGTON MANAGEMENT ownership change
10 Aug 20
SC 13G
NanoString / WELLINGTON MANAGEMENT ownership change
10 Aug 20
SC 13G
Churchill Capital Corp III / WELLINGTON MANAGEMENT ownership change
10 Aug 20
SC 13G/A
Revance Therapeutics / WELLINGTON MANAGEMENT ownership change
10 Aug 20